Published Feb 24, 2024
No Mercy / No Malice: Corporate Ozempic
Scott Galloway draws a compelling parallel between AI's transformative influence on corporate strategies and GLP-1 drugs, revealing how AI enhances productivity and spurs innovation while paradoxically coinciding with tech layoffs despite strong financial gains.
Topics covered
Popular Clips
Episode Highlights
Related Episodes
Dr. Lex Fridman: Machines, Creativity & Love | Huberman Lab Podcast #29
Answers 383 questionsAMA #8: Balancing Caffeine, Decision Fatigue & Social Isolation
Answers 383 questionsAMA #17: Making Time for Fitness, Top Sleep Tools & Best Learning Strategies
Answers 383 questionsAMA #14: 2023 Philanthropy, Evening Routine, Light Therapy, Health Metrics & More
Answers 383 questions
Dr. Jamil Zaki: How to Cultivate a Positive, Growth-Oriented Mindset
Answers 383 questions
Dr. Terry Sejnowski: How to Improve at Learning Using Neuroscience & AI
Answers 383 questions
Dr. Kyle Gillett: Tools for Hormone Optimization in Males | Huberman Lab Podcast 102
Answers 383 questionsAMA #15: Fluoride Benefits/Risks & Vagus Nerve Stimulation
Answers 383 questionsLIVE EVENT Q&A: Dr. Andrew Huberman at the Sydney Opera House
Answers 383 questionsTools to Enhance Working Memory & Attention
Answers 383 questions
Asi Wind: What Magic & Mind Reading Reveal About the Brain
Answers 383 questionsAMA #16: Sleep, Vertigo, TBI, OCD, Tips for Travelers, Gut-Brain Axis & More
Answers 383 questions
